Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-intensity Shockwave Therapy Versus Solifenacin for Overactive Bladder in Women
NCT07473310Phase 4Recruiting
- Sponsor
- Mansoura University
- Start
- Nov 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in overactive bladder (OAB) (2 arms), sponsored by Mansoura University. Primary endpoint: Overactive Bladder Symptom Score at 3 months. Started Nov 2025; status: recruiting.
02
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07473310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07473310.